Published in Oncology Business Week, March 12th, 2006
According to recent research published in the journal Cancer Immunology, Immunotherapy, "Multiple myeloma (MM) remains incurable despite the use of high-dose chemotherapy and stem cell transplantation. However, immunotherapy is expected to offer long-term disease control, or even possibly a cure."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week